BackZogenix Overview

Zogenix Current Cash

Track Zogenix's current cash ($300M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$301.71M
↓ 40.27% YoYΔ $-203.39M vs prior year quarter

Peer trimmed avg / median

Loading

Zogenix Current Cash History

Loading

Zogenix vs. peers: Current Cash Comparison

Loading

Zogenix Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Zogenix (ZGNX) FAQ

Zogenix (ZGNX) currently reports a current cash of $300M as of December 2021. That compares with $510M in the prior-year period — down 40.3% year over year. Use the charts on this page to explore Zogenix's current cash history and peer comparisons.

Zogenix's current cash decreased from $510M to $300M — a 40.3% year-over-year decrease (period ending December 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Zogenix reported $300M in current cash as of December 2021. That compares with $510M in the prior-year period — down 40.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $300M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Zogenix, and consider following ZGNX for alerts when major investors trade the stock.

Zogenix is classified in the Healthcare sector. On current cash, it currently shows $300M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ZGNX with unrelated industries.